title: Acute gastrointestinal bleeding after percutaneous coronary intervention.
abstract: Bleeding from the GI tract is a commonly encountered clinical problem after percutaneous coronary intervention. The GI tract is likely to become the most commonly encountered site of bleeding as cardiologists adopt smaller access sheath sizes, percutaneous closure devices and a radial artery approach, further reducing access-site bleeding. To appropriately manage gastrointestinal bleeding in this setting, the clinician must strike a balance between arresting hemorrhage and preventing ischemic coronary complications. To do so, an appreciation of both cardiovascular and gastrointestinal issues is required. This review aims to provide the required knowledge, as well as a series of recommendations from our practice, to assist in the management of this potentially fatal complication.
authors.affiliation: Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, WA 6001, Australia. michael.wallace2@health.wa.gov.au
authors.forename: Michael C
authors.initials: MC
authors.lastname: Wallace
authors.forename: Jamie
authors.initials: J
authors.lastname: Rankin
authors.forename: Geoffrey M
authors.initials: GM
authors.lastname: Forbes
mesh_terms: D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors